St. Jude Medical, Inc. , a global medical device company, today announced U.S. Food and Drug Administration approval of its TactiCath™ Quartz irrigated ablation catheter, the company’s newest technology that gives physicians a real-time, objective measure of the force that the catheter applies to a patient’s heart wall during an ablation procedure.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1yFFi8D
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1yFFi8D
via IFTTT
No comments:
Post a Comment